Opus Genetics’ OPGx-BEST1 cleared to enter clinic BioWorld MedTechOpus Genetics Announces FDA Clearance of IND Application for Gene Therapy Candidate OPGx-BEST1 Yahoo FinanceFDA clears Opus Genetics’ IND for BEST1 IRD gene therapy Eyes On EyecareOpus Genetics shares fall 4.17% intraday after FDA clearance of IND for OPGx-BEST1 gene therapy. AInvestFDA clears Opus Genetics’ IND for BEST1 gene therapy Investing.com
